The Department of the Army awarded Medea Inc., doing business as Medea Medical Products, a $62.4 million firm fixed price definitive contract to supply COVID-19 antigen over-the-counter test kits. Medea will provide the iHealth and Acon brand test kits identified in the Army's December 2021 special notice seeking information on the availability of FDA Emergency Use Authorized or 510(k) cleared rapid antigen tests to support personnel testing through April 2022. The Department of the Army Materiel Command and Department of Health and Human Services issued the special notice on behalf of the Department of Defense and Department of Health and Human Services. Medea will deliver the test kits to the Army for distribution and use, with performance taking place in Pleasanton, California. The contract is funded by the Department of the Army to support the military's ongoing COVID-19 medical response efforts.
Generated 12/29/23, 4:34 PM